ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years
Lu Qiao
Matched on ORCID iD 0000-0002-9037-5927; OpenAlex author ID A5101075903. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper
Papers 5
- KLF15 suppresses stemness of pancreatic cancer by decreasing USP21-mediated Nanog stability. Co-author DOI 10.1007/s00018-024-05442-6↗
- Aberrant lactate dehydrogenase A signaling contributes metabolic signatures in pancreatic cancer. First author DOI 10.21037/atm-21-295↗
- Pancreatic stellate cells regulate branched-chain amino acid metabolism in pancreatic cancer. First author DOI 10.21037/atm-21-761↗
- TOB1 suppresses proliferation in K-Ras wild-type pancreatic cancer. First author DOI 10.1002/cam4.2756↗
- Identification of Upregulated HNRNPs Associated with Poor Prognosis in Pancreatic Cancer. Co-author DOI 10.1155/2019/5134050↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Wenna Jiang · 3 shared papers, 2021–2024 · strength 0.48
- Paper KLF15 suppresses stemness of pancreatic cancer by decreasing USP21-mediated Nanog stability. DOI 10.1007/s00018-024-05442-6↗
- Paper Pancreatic stellate cells regulate branched-chain amino acid metabolism in pancreatic cancer. DOI 10.21037/atm-21-761↗
- Paper Aberrant lactate dehydrogenase A signaling contributes metabolic signatures in pancreatic cancer. DOI 10.21037/atm-21-295↗
- Duo Zuo · 2 shared papers, 2021–2024 · strength 0.33
- Li Ren · 2 shared papers, 2021 · strength 0.28
- Yuru Bai · 2 shared papers, 2019–2020 · strength 0.22
- Ning Xie · 2 shared papers, 2019–2020 · strength 0.22
- Meng Wang · 1 shared paper, 2024 · strength 0.20
- Li Ren · 1 shared paper, 2024 · strength 0.20
- Tianxing Zhou · 1 shared paper, 2024 · strength 0.20
- Jing Liu · 1 shared paper, 2024 · strength 0.20
- Na Liu · 1 shared paper, 2020 · strength 0.11
- Na Liu · 1 shared paper, 2019 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.